Overview
What is Aim At Melanoma?
Aim At Melanoma is a globally engaged and locally invested nonprofit organization dedicated to advancing the fight against melanoma. Through innovative research, legislative reform, education, and patient and caregiver support, Aim At Melanoma aims to expedite the discovery of a cure for melanoma. With a strong focus on collaboration, the organization brings together leading global researchers, funds their collaborative research projects, and advocates for patients and their families. Aim At Melanoma provides a comprehensive, easily accessible online resource hub for patients, survivors, and caregivers, as well as educational materials for medical professionals. The organization also offers a physician assistant on call service, patient advocacy events, and a peer-to-peer support program to connect melanoma patients and their loved ones with one another. With a presence in numerous countries, Aim At Melanoma continues to support and mentor patient advocacy groups worldwide, facilitating their participation in international melanoma meetings and assisting in the development of their respective websites.
Official website here: www.aimatmelanoma.org
Is Aim At Melanoma legitimate?
Aim At Melanoma is a legitimate nonprofit organization registered as a 501(c)(3) entity. Aim At Melanoma submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $347,008
Professional Fundraising Fees: $0
Other Salaries and Wages: $339,108
For more financial information, click here
Official website here: www.aimatmelanoma.org
What is the mission statement of Aim At Melanoma?
Aim At Melanoma is a global organization committed to advancing the fight against melanoma through innovative research, legislative reform, education, and patient and caregiver support. Established in 2004, it is the largest international melanoma foundation seeking a cure for the disease. Aim At Melanoma believes that the cure for melanoma can be found more quickly by bringing together leading global researchers and funding their collaborative research. The organization has three paradigm-shifting global research initiatives, including the Melanoma Tissue Bank Consortium, which are poised to reshape the future of melanoma. Aim At Melanoma is a respected voice in the melanoma community, advocating for patients and their families at key moments, such as when drugs are approved, legislation is drafted, and research is assessed. It serves as a trusted advisor to pharmaceutical companies, medical boards, and government agencies on critical topics affecting melanoma patients.
Official website here: www.aimatmelanoma.org
Who is the CEO of Aim At Melanoma?
What is the revenue of Aim At Melanoma?
Who are the executives of Aim At Melanoma and what are their salaries?
The average compensation at Aim At Melanoma during 2022 was $76,235. There are 9 employees at Aim At Melanoma.
Here are 6 key members and their salaries:
- Samantha Guild (President And Director)
- Alicia Rowell (Vice President)
- John Kirkwood (Director)
- Mohammed Kashani-Sabet (Director)
- Renu Gupta (Director)
- Howard Maibach (Director)
Official website here: www.aimatmelanoma.org
Where can I find the form 990 for Aim At Melanoma?
The Aim At Melanoma’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.aimatmelanoma.org
Learn more at the official website: www.aimatmelanoma.org
Mission Statement of Aim At Melanoma
Aim At Melanoma, established in 2004, is a globally engaged and locally invested organization committed to advancing the battle against melanoma. Its mission is multifaceted, encompassing innovative research, legislative reform, education, and patient and caregiver support. This nonprofit organization, recognized as the largest international melanoma foundation seeking a cure, believes that collaborative research among leading global researchers will accelerate the discovery of a cure for melanoma.
Aim At Melanoma is the respected voice in the melanoma community, participating actively in drug approvals, legislation drafting, and research assessment. By bringing together researchers, pharmaceutical companies, medical boards, and government agencies, it aims to influence critical topics that impact melanoma patients and their families. The organization's three paradigm-shifting global research initiatives, including the Melanoma Tissue Bank Consortium, are poised to transform the future of melanoma research.
In summary, Aim At Melanoma is a mission-driven organization that supports melanoma research, promotes prevention and education among the general public and medical professionals, and provides comprehensive and easily accessible resources for patients, survivors, and caregivers. It is committed to reshaping the future of melanoma through innovative research, legislative reform, education, and patient and caregiver support, working collaboratively with leading global researchers and influential organizations to find a cure for melanoma.
Impact
This information is meant to be a general summary of Aim At Melanoma. Please take the time to review official sources before making any decisions based upon the content provided here.
Saturday, July 20, 2024
Aim At Melanoma has had a significant impact in the fight against melanoma by supporting melanoma research, promoting prevention and education, and providing comprehensive resources for patients, survivors, and caregivers. Through various initiatives such as maintaining a comprehensive website, offering a physician assistant on-call service, organizing patient advocacy events, and providing peer-to-peer support through programs like Peer Connect, Aim At Melanoma has been able to reach and assist a wide range of individuals in the melanoma community.
Furthermore, Aim At Melanoma has expanded its reach globally by supporting and mentoring patient advocacy groups in various countries. The organization has also established the International Melanoma Working Group (IMWG) to facilitate collaboration among leading melanoma experts worldwide, with a focus on advancing research and developing more effective treatment options for melanoma patients.
In addition, initiatives like Women in Melanoma and the Melanoma Nurse Initiative have further contributed to improving patient outcomes by strengthening relationships between physicians and patients, fostering mentorship among women oncologists in the field of melanoma, and providing educational resources for melanoma nurses.
Overall, Aim At Melanoma's impact extends across various fronts, from patient advocacy and support to global research collaborations, making a significant contribution to the fight against melanoma and the improvement of patient care and outcomes.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CONSULTING
Revenue
$5,000
HONORARIUM
Revenue
$4,500
Organization Details
Founding Year
2004
Phone
(916) 706-0599
Principal Officer
Samantha Guild
Main Address
3040 CUTTING BLVD, RICHMOND, CA, 94804
Website
www.aimatmelanoma.org
NTEE Category
Code: G30 - Disease
If you are a representative of Aim At Melanoma and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.